Towards European harmonisation of healthcare for patients with rare immune disorders: outcome from the ERN RITA registries survey
Publication date
2020-01-30
Authors
ERN RITA Council
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
Abstract
The Rare Immunodeficiency, AutoInflammatory and AutoImmune Disease (RITA) network is a European Research Network (ERN) that brings together the leading centres for rare immune disorders. On April 2018 an online survey was sent to all RITA members in order to facilitate the harmonization of data collection in rare immune disorders registries. Currently, as many as 52 different registries collect data on rare immune disorders, of whom 30 (58%) are dedicated primarily to autoimmune diseases, 15 (29%) to primary immunodeficiencies and 12 (23%) to autoinflammatory disorders. Improving data on patient safety, outcome, and quality of life measures is warranted to unfold the full potential of RITA registries.
Keywords
Autoimmune disorders, Autoinflammatory diseases, Disease registry, European research network, Primary immunodeficiency, Genetics(clinical), Pharmacology (medical), Letter
Citation
ERN RITA Council 2020, 'Towards European harmonisation of healthcare for patients with rare immune disorders : outcome from the ERN RITA registries survey', Orphanet Journal of Rare Diseases, vol. 15, no. 1, 33, pp. 1-7. https://doi.org/10.1186/s13023-020-1308-x